Semaglutide for teens after weight-loss surgery
Part of Hormones & metabolism clinical trials.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to 24 years old
- You are planning to have a sleeve gastrectomy or have had one within the last 6 to 24 months
- If you already had surgery, you have not lost more than 22% of your body weight
- You do not have type 2 diabetes or certain other medical conditions like thyroid cancer or pancreatitis
- You are not using insulin or certain other weight-loss or diabetes medications now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if semaglutide (a weekly injection) helps people who lost less weight than expected after gastric bypass or sleeve surgery. It's for patients who had a high BMI before surgery and are in a special support program.
This study tests whether semaglutide (a once-weekly injection that helps with weight loss) can help teenagers with autism who are obese. It will compare their results to similar teens who did not take the drug to see if it is safe and effective.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.